Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3779
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Gansner, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Clinical Fellow in Medicine at Brigham and Women's Hospital.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
WashU MedicineClass of 2010
Certifications & Licensure
MA State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 9 citationsEfficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.Jeffrey M Saland, John C Lieske, Jaap W Groothoff, Yaacov Frishberg, Hadas Shasha-Lavsky
Kidney International Reports. 2024-07-01 - 6 citationsEfficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial.Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, David J Sas, Mini Michael
Frontiers in Pediatrics. 2024-01-01 - 3 citationsQuantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials.Valerie A Clausen, Karen H Cao, John M Gansner, Gabriel J Robbie, Jing-Tao Wu
Bioanalysis. 2023-05-01
